MY-1576

MY-1576 is a potent FAK inhibitor (IC50 = 8 nM) that activates the Hippo pathway to suppress YAP/TAZ activity. It demonstrates robust anti-tumor efficacy in KYSE30 xenograft models and effectively reduces FAK autophosphorylation and YAP/TAZ levels in vivo, supporting its use in cancer research.